<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Clinical Case Study - M.B.</title>
  <style>
    * {
      box-sizing: border-box;
      scroll-behavior: smooth;
    }

    body {
      margin: 0;
      font-family: 'Segoe UI', sans-serif;
      background-color: #ffffff;
      color: #333;
      display: flex;
      flex-direction: row;
    }

    .sidebar {
      position: sticky;
      top: 0;
      width: 120px;
      background-color: #f5f5f5;
      padding: 20px 10px;
      height: 100vh;
      display: flex;
      flex-direction: column;
      align-items: center;
      gap: 20px;
      transition: width 0.3s ease;
      overflow-x: hidden;
    }

    .sidebar a {
      writing-mode: vertical-rl;
      transform: rotate(180deg);
      text-decoration: none;
      color: #333;
      font-weight: bold;
      margin: 10px 0;
    }

    .main-content {
      flex: 1;
      padding: 0 20px;
    }

    header { background-color: #ffffff;$1
      border-bottom: 1px solid #ccc;
      border-radius: 10px;
      box-shadow: 0 2px 4px rgba(0,0,0,0.1);

    header img {
      height: 60px;
    }

    .header-text {
      text-align: center;
      flex: 1;
    }

    .header-text h1 {
      margin: 0;
      font-size: 1.25rem;
      font-weight: bold;
    }

    .header-text h2 {
      margin: 5px 0;
      font-size: 1rem;
      font-weight: normal;
      font-style: italic;
    }

    .header-text p {
      margin: 5px 0;
      font-size: 0.9rem;
    }

    section {
      margin: 40px 0;
      padding: 20px;
      background-color: #ffffff;
      border-radius: 10px;
      box-shadow: 0 2px 4px rgba(0,0,0,0.1);
    }

    section h2 {
      margin-top: 0;
    }

    @media (max-width: 768px) {
      body {
        flex-direction: column;
      }

      .sidebar {
        flex-direction: row;
        width: 100%;
        height: auto;
        justify-content: space-around;
        padding: 10px;
      }

      .sidebar a {
        writing-mode: initial;
        transform: none;
      }
    }
      .abnormal {
      color: red;
      background-color: #ffe5e5;
      animation: flash-bg 1.5s infinite;
    }

    @keyframes flash-bg {
      0% { background-color: #ffe5e5; }
      50% { background-color: transparent; }
      100% { background-color: #ffe5e5; }
    }
    .sidebar-toggle {
      position: absolute;
      top: 10px;
      left: 10px;
      background-color: #007acc;
      color: #fff;
      border: none;
      padding: 8px 12px;
      cursor: pointer;
      border-radius: 4px;
      font-size: 14px;
      z-index: 1001;
    }

    .sidebar.collapsed {
      width: 50px;
      overflow: hidden;
    }

    .sidebar.collapsed a {
      display: none;
    }

    .sidebar.collapsed img {
      width: 30px;
      height: 30px;
    }

    @media (max-width: 768px) {
      .sidebar {
        flex-direction: row;
        width: 100%;
        height: auto;
        justify-content: space-around;
        padding: 10px;
      }

      .sidebar a {
        writing-mode: initial;
        transform: none;
      }
    }
    .abnormal {
      color: red;
      animation: flash-bg 1.5s infinite;
    }

    @keyframes flash-bg {
      0% { background-color: #ffe5e5; }
      50% { background-color: transparent; }
      100% { background-color: #ffe5e5; }
    }
</style>
</head>
<body>
  

  <div class="sidebar">
    <img src="./qr.png" alt="QR Code" style="width:60px; height:60px;">
    <a href="#case-summary">Summary</a>
    <a href="#timeline">Timeline</a>
    <a href="#labs">Labs</a>
    <a href="#biopsy">Biopsy</a>
    <a href="#takeaways">Takeaways</a>
    <a href="#literature">Literature</a>
    <a href="#management">Management</a>
    <a href="#diagnosis">Diagnosis</a>
  </div>

  <div class="main-content">
    <header>
      <img src="./a.png" alt="Logo 2">
      <div class="header-text">
        <h1>Rapidly Progressive Glomerulonephritis due to IgA Nephropathy:</h1>
        <h2>A Rare Presentation of a Common Disease</h2>
        <p>Dr. Alaa Alsaqqa, Pediatric Nephrology Fellow ‚Äì Year 1</p>
        <p>Supervisor: Dr. Samhar Al-Akash, Pediatric Nephrologist Consultant</p>
      </div>
      <img src="./b.png" alt="Logo 1">
    </header>

    <section id="case-summary">
      <h2>üìù Case Summary </h2>
      <p><strong>M.B.</strong>, 14-year-old male, previously healthy with no significant family history, presented in Syria with the following:</p>
      <ul>
        <li><strong>Initial Presentation (June‚ÄìJuly 2024):</strong> Low grade fever, flu-like illness, fatigue, pallor, reduced appetite, weight loss (6 kg), gross hematuria.</li>
        <li><strong>Subsequent Course:</strong> Reduced urine output, elevated blood pressure, respiratory distress, lower limb swelling (signs of fluid overload).</li>
        <li><strong>AJCH Presentation (January 2025):</strong> After missing several hemodialysis sessions due to travel and financial reasons ‚Äì uncontrolled hypertension/hypertensive emergency, headache, epistaxis, abdominal pain, increasing fatigue, lower limb edema and pallor.</li>
      </ul>
    </section>

    <section id="timeline">
      <h2>üóìÔ∏è Case Timeline </h2>
      <div style="position: relative; max-width: 100%;">
        <img src="./timeline.png" usemap="#timeline-map" style="width: 100%; height: auto; border-radius: 10px; box-shadow: 0 2px 4px rgba(0,0,0,0.1);">
        <map name="timeline-map">
          <area shape="circle" coords="60,90,15" href="#july17" alt="July 17">
          <area shape="circle" coords="60,170,15" href="#aug1" alt="August 1">
          <area shape="circle" coords="60,250,15" href="#oct7" alt="October 7">
          <area shape="circle" coords="60,330,15" href="#nov2" alt="November 2">
          <area shape="circle" coords="60,410,15" href="#jan3" alt="January 3">
          <area shape="circle" coords="600,90,15" href="#jun-jul" alt="June-July">
          <area shape="circle" coords="600,170,15" href="#jul27" alt="July 27">
          <area shape="circle" coords="600,250,15" href="#aug26" alt="August 26">
          <area shape="circle" coords="600,330,15" href="#oct28" alt="October 28">
          <area shape="circle" coords="600,410,15" href="#nov29" alt="November 29">
        </map>
      </div>
    </section>

    <section id="labs">
        <h2>üß™ Laboratory Findings </h2>
        <div style="overflow-x:auto">
          <table style="width:100%; border-collapse:collapse; text-align:center; font-size:14px;">
            <thead style="background-color:#e1e9f6; color:#003366;">
              <tr>
                <th style="border:1px solid #ccc; padding:8px;">Parameter</th>
                <th style="border:1px solid #ccc; padding:8px;">July 2024</th>
                <th style="border:1px solid #ccc; padding:8px;">January 2025</th>
                <th style="border:1px solid #ccc; padding:8px;">Reference Range</th>
              </tr>
            </thead>
            <tbody>
  <tr style="background-color: #f9f9f9;"><td>WBC</td><td>-</td><td>6.5 n/L</td><td>5‚Äì13 n/L</td></tr>
  <tr><td>Hemoglobin</td><td class="abnormal">6.5 g/dL</td><td class="abnormal">6.7 g/dL</td><td>11.5‚Äì15.5 g/dL</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Platelet</td><td>-</td><td class="abnormal">91 n/L</td><td>170‚Äì450 n/L</td></tr>
  <tr><td>Creatinine</td><td class="abnormal">6.7 mg/dL</td><td class="abnormal">6.7 mg/dL</td><td>0.44‚Äì0.65 mg/dL</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Urea</td><td>-</td><td class="abnormal">132 mg/dL</td><td>19.26‚Äì47.2 mg/dL</td></tr>
  <tr><td>Sodium</td><td>-</td><td>136 mmol/L</td><td>136‚Äì145 mmol/L</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Potassium</td><td>-</td><td class="abnormal">4.6 mmol/L</td><td>3.5‚Äì5.1 mmol/L</td></tr>
  <tr><td>Phosphate</td><td class="abnormal">8.4 mg/dL</td><td>5.6 mg/dL</td><td>3.5‚Äì6.2 mg/dL</td></tr>
  <tr style="background-color: #f9f9f9;"><td>LDH</td><td>-</td><td class="abnormal">482 U/L</td><td>170‚Äì283 U/L</td></tr>
  <tr><td>C3, C4</td><td>Normal</td><td>Normal</td><td>-</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Ferritin</td><td>-</td><td class="abnormal">4985 ng/mL</td><td>13.7‚Äì78.8 ng/mL</td></tr>
  <tr><td>24h urine protein</td><td class="abnormal">3000 mg/24h</td><td>-</td><td><500 mg/24h</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Urine protein/creatinine</td><td class="abnormal">11.1 g/g</td><td class="abnormal">3.97 g/g</td><td><0.2 g/g</td></tr>
  <tr><td>C-ANCA, P-ANCA</td><td>Normal</td><td>Negative</td><td>-</td></tr>
  <tr style="background-color: #f9f9f9;"><td>Anti-dsDNA, ANA</td><td>Normal</td><td>Negative</td><td>-</td></tr>
  <tr><td>Anti-GBM</td><td>Normal</td><td>Negative</td><td>-</td></tr>
  <tr style="background-color: #f9f9f9;"><td>HIV, HCV</td><td>Normal</td><td>Negative</td><td>-</td></tr>
  <tr><td>IgA</td><td class="abnormal">0.19 g/dL</td><td class="abnormal">0.21 g/dL</td><td>0.47‚Äì2.49 g/dL</td></tr>
  <tr style="background-color: #f9f9f9;"><td>IgG</td><td>-</td><td class="abnormal">2.25 g/dL</td><td>7.16‚Äì17.11 g/dL</td></tr>
  <tr><td>PTH</td><td>-</td><td class="abnormal">80 pg/mL</td><td>15‚Äì65 pg/mL</td></tr>
  </tbody>
          </table>
        </div>
        <br>
        <h4>Other Investigations</h4>
        <ul>
          <li><strong>USS Kidneys:</strong> Both kidneys normal in size with diffuse increased renal cortical echotexture. Corticomedullary differentiation maintained. No hydronephrosis.</li>
          <li><strong>Blood film:</strong> Mild normocytic normochromic anemia and reactive picture.</li>
          <li><strong>ECHO:</strong> Mild pericardial effusion, mild LVH, good cardiac function.</li>
        </ul>
      </section>
    <section id="biopsy">
      <h2>üî¨ Kidney Biopsy Results </h2>
      <p><strong>First Kidney Biopsy (26/08/2024)</strong><br>
      Focal necrotizing GN (advanced chronic changes with scarring in the glomeruli and mild activity).</p>

      <p><strong>Second Kidney Biopsy (03/01/2025)</strong></p>

      <div style="display: flex; flex-wrap: wrap; gap: 20px; justify-content: center;">
        <div style="text-align: center; max-width: 30%;">
          <img src="./Picture1.png" alt="PAS stain showing a sclerotic" style="width: 100%; border-radius: 10px;">
          <p>PAS stain showing a sclerotic</p>
        </div>
        <div style="text-align: center; max-width: 30%;">
          <img src="./Picture2.png" alt="PAS stain Segmental scar" style="width: 100%; border-radius: 10px;">
          <p>PAS stain Segmental scar, fibrous Crescent and mesangial Hypercellularity in the preserved Portion of the glomerulus</p>
        </div>
        <div style="text-align: center; max-width: 30%;">
          <img src="./Picture3.png" alt="Jones stain showing Globally sclerotic" style="width: 100%; border-radius: 10px;">
          <p>Jones stain showing Globally sclerotic Glomerulus with an Old fibrous crescent</p>
        </div>
        <div style="text-align: center; max-width: 30%;">
          <img src="./Picture4.png" alt="Trichrome showing Severe fibrosis" style="width: 100%; border-radius: 10px;">
          <p>Trichrome showing Severe fibrosis</p>
        </div>
        <div style="text-align: center; max-width: 30%;">
          <img src="./Picture5.png" alt="IF: IgA staining in a Segmentally sclerotic glomerulus" style="width: 100%; border-radius: 10px;">
          <p>IF: IgA staining in a Segmentally sclerotic glomerulus</p>
        </div>
      </div>
    <br>
      <h4>Detailed Findings of Second Biopsy</h4>
      <div style="overflow-x:auto">
        <table style="width:100%; border-collapse:collapse; text-align:left; font-size:14px;">
          <thead style="background-color:#e1e9f6; color:#003366;">
            <tr>
              <th style="border:1px solid #ccc; padding:8px; background-color:#d0d7e9;">Category</th>
              <th style="border:1px solid #ccc; padding:8px; background-color:#d0d7e9;">Findings</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:1px solid #ccc; padding:8px;"><strong>Glomerular (Total: 40)</strong></td>
              <td style="border:1px solid #ccc; padding:8px;">
                - 36/40 (90%): Globally sclerotic<br>
                - 4/40 (10%): Patent but show segmental sclerosis, hyalinosis, and adhesion to Bowman's capsule
              </td>
            </tr>
            <tr style="background-color: #f9f9f9;">
              <td style="border:1px solid #ccc; padding:8px;"><strong>Light Microscopy</strong></td>
              <td style="border:1px solid #ccc; padding:8px;">
                - Mesangial matrix: Mild increase<br>
                - Mesangial & endocapillary hypercellularity (PAS stain) M1, E1 (Oxford score)<br>
                - Capillary wall thickening, but no spikes or holes (silver stain)<br>
                - No cellular crescents or fibrinoid necrosis<br>
                - Fibrous crescents in all glomeruli on toluidine blue<br>
                - Tubulointerstitial changes: Mild acute tubular injury<br>
                - Interstitial inflammation: Mild, with lymphocytes & plasma cells<br>
                - Tubular atrophy & interstitial fibrosis: 70% of cortex (T2)<br>
                - Vessels: Larger arteries normal, mild arteriolar hyalinosis
              </td>
            </tr>
            <tr>
              <td style="border:1px solid #ccc; padding:8px;"><strong>Immunofluorescence</strong></td>
              <td style="border:1px solid #ccc; padding:8px;">
                - Glomeruli in IF: 11 total, 10 globally sclerotic<br>
                - Granular mesangial staining: IgA (2+), IgG (2+), IgM (trace), C3 (2+), kappa (2+), lambda (1‚Äì2+)<br>
                - All other stains negative
              </td>
            </tr>
            <tr style="background-color: #f9f9f9;">
              <td style="border:1px solid #ccc; padding:8px;"><strong>Electron Microscopy</strong></td>
              <td style="border:1px solid #ccc; padding:8px;">
                - GBM normal thickness but diffusely wrinkled<br>
                - No subepithelial, subendothelial, or intramembranous deposits<br>
                - Mild mesangial matrix increase with mesangial deposits<br>
                - Widespread podocyte foot process effacement
              </td>
            </tr>
          </tbody>
        </table>
      </div>
    </section>

    <section id="takeaways">
      <h2>üìå Key Takeaways </h2>
      <ul style="list-style: none; padding: 0;">
        <li style="background-color: #e6f4fd; padding: 10px; margin-bottom: 8px; border-left: 4px solid #007acc;">
          IgA Nephropathy in children may rarely present with a rapidly progressive GN picture
        </li>
        <li style="background-color: #e6f4fd; padding: 10px; margin-bottom: 8px; border-left: 4px solid #007acc;">
          Aggressive therapy is recommended for RPGN due to IgA Nephropathy
        </li>
        <li style="background-color: #e6f4fd; padding: 10px; margin-bottom: 8px; border-left: 4px solid #007acc;">
          End-stage kidney disease may still develop despite aggressive therapy
        </li>
        <li style="background-color: #e6f4fd; padding: 10px; margin-bottom: 8px; border-left: 4px solid #007acc;">
          Urine output may be restored even when kidney function does not significantly improve
        </li>
      </ul>
    </section>

    <section id="literature">
      <h2>üìö Literature Review </h2>
      <p>IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. While typically characterized by a slowly progressive course, approximately 5% of patients present with rapidly progressive glomerulonephritis (RPGN).</p>

      <p>Recent studies suggest that aggressive immunosuppressive therapy combining steroids with cyclophosphamide or rituximab may improve outcomes in severe cases, particularly when initiated early.</p>

      <p>The Oxford Classification for IgAN (MEST-C score) helps stratify risk and guide treatment decisions. This patient's score (M1 E1 S1 T2 C0) indicates mesangial hypercellularity, endocapillary hypercellularity, segmental glomerulosclerosis, and severe tubular atrophy/interstitial fibrosis, all associated with poorer prognosis.</p>
    </section>

    <section id="management">
      <h2>ü©∫ Current Management </h2>
      <ul style="list-style: none; padding: 0;">
        <li style="background-color: #f0f9f1; padding: 10px; margin-bottom: 8px; border-left: 4px solid #28a745;">
          Lifestyle modification and diet control
        </li>
        <li style="background-color: #f0f9f1; padding: 10px; margin-bottom: 8px; border-left: 4px solid #28a745;">
          Blood pressure control (currently on amlodipine)
        </li>
        <li style="background-color: #f0f9f1; padding: 10px; margin-bottom: 8px; border-left: 4px solid #28a745;">
          Regular hemodialysis
        </li>
        <li style="background-color: #f0f9f1; padding: 10px; margin-bottom: 8px; border-left: 4px solid #28a745;">
          Vitamin D supplementation
        </li>
        <li style="background-color: #f0f9f1; padding: 10px; margin-bottom: 8px; border-left: 4px solid #28a745;">
          Undergoing evaluation for kidney transplant
        </li>
      </ul>
    </section>

    <section id="diagnosis">
      <h2>‚úÖ Final Diagnosis </h2>
      <p><strong>Rapidly Progressive Glomerulonephritis due to IgA Nephropathy</strong></p>
    </section>
  </div>

<script>
  const toggleButton = document.querySelector('.sidebar-toggle');
  const sidebar = document.querySelector('.sidebar');

  toggleButton.addEventListener('click', () => {
    sidebar.classList.toggle('collapsed');
  });
</script>
</body>
</html>
